IMMUNINE VH
IMMUNINE VH
Approved
DIN Number
02206021
Drug Class
Human
Market Date
Oct 18, 1996
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02206021
AIG Number0128463008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD04 COAGULATION FACTOR IX
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
COAGULATION FACTOR IX (HUMAN)Active
Strength: 720 UNIT / 5 ML
Monograph: COAGULATION FACTOR IX (HUMAN)